Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Alpha Cognition Inc
ACOGF
Primary Symbol:
C.ACOG
Healthcare
Biotechnology
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062...
is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:ACOG)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(127)
•••
SkywalkerofLuke
X
View Profile
View Bullboard History
Post by
SkywalkerofLuke
on Dec 10, 2021 6:54pm
Interview with $ACOG CEO
Found this interview with the CEO of $ACOG $ACOG.v that discusses the data they collected from a pre-clinical study of ALPHA-1062 for traumatic brain injuries. Highlights - ALPHA-1062
...more
(144)
•••
culturedpiggy01
X
View Profile
View Bullboard History
Post by
culturedpiggy01
on Dec 09, 2021 4:18pm
$ACOG.V 's new TBI clinical study featured in The Power Play
$ACOG.v has been featured in the The Power Play by The Market Herald as they announce results from pre-clinical study of ALPHA-1062. They reported that administering ALPHA-1062 reduced the
...more
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net
posted May 02, 2024 9:00am by
Xcyte Digital Corp.
-
|
"The addition of Webinar.net further enhances Xcyte's suite of solutions by adding a technology platform that was built for and hosted on the cloud with enterprise grade scale and security. Webinar.net infrastructure is built to handle millions of online presentation attendees from global businesses. This acquisition further enhances our revenue and EBITDA growth in alignment with our medium-term expansion objectives ...read more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Dec 08, 2021 7:08am
$ACOG shares saw big gain yesterday
Alpha Cognition has announced the functional data from their ALPHA-1062 intranasal Traumatic Brain Injury (TBI) program. Administration of the drug proved to reduce the extent of the functional
...more
(1836)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Dec 07, 2021 4:21pm
The Power Play by The Market Herald Releases New Interviews
(Sponsored) Alpha Cognition (ACOG) has announced the functional data from their ALPHA-1062 intranasal Traumatic Brain Injury (TBI) program. Administering ALPHA-1062 reduced the extent of the
...more
(75)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Dec 07, 2021 1:07pm
$ACOG in the green after successful animal trials of A-1062
However, this new study found that Alpha-1062 also reduced the extent of functional deficits, and improved functional recovery of animals with TBI so effectively that in most functional measures of
...more
(12)
•••
ferret_ca
X
View Profile
View Bullboard History
Comment by
ferret_ca
on Dec 06, 2021 3:48pm
RE:$ACOG study shows that their A-1062 drug helps with TBI
I see the market is just thrilled with this announcement, lol. someone wanted out, big drop for not much volume, lets see if any insiders step in and buy any down here.
(75)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Dec 06, 2021 2:26pm
$ACOG study shows that their A-1062 drug helps with TBI
As boomers begin to enter old age more and more of the population will be elderly. This fundamental change in the makeup of our population should be kept in mind when making long-term investments and
...more
(5566)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Dec 06, 2021 11:12am
RE:Good News
Make that still in the red. Was looking across at a long list and inadvertantly looked at the one above ACOG.
(5566)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Dec 06, 2021 11:07am
Good News
And yet we've barely moved (and were earlier in the red). Two potential reasons: minor tax loss selling and the fact that this company is essentially unknown. GLTA Alpha Cognition Inc. (TSX-V
...more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Dec 05, 2021 4:16pm
$ACOG appoints new CMO
Alpha Cognition $ACOG/$ACOG.V has appointed Cedric O’Gorman as their chief medical officer. Gorman will lead medical, clinical and regulatory functions in support of the company’s clinical-stage
...more
(75)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Dec 02, 2021 4:48pm
Internal news for $ACOG.V (new CMO)
Big internal news for Alpha Cognition ( $ACOG.V/$ACOGF ) The biopharmaceutical company announced today that they have appointed Dr.Cedric O’Gorman (M.D.) as their Chief Medical Officer. O&
...more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Dec 01, 2021 12:12pm
$ACOG completed q3 with $5.6M in cash and equivalents
Alpha Cognition released some strong third-quarter numbers yesterday, stating they’ve completed Q3 with 5.6 million in cash and equivalents. Following this news, shares have strongly broken
...more
(36)
•••
Justdosomedd
X
View Profile
View Bullboard History
Post by
Justdosomedd
on Nov 30, 2021 5:08pm
Q3 Financials Are Out
$ACOG just reported their 3rd quarter results. Despite the overall market being down 1.7%+, $ACOG is up 2.7%. So let's dive into these results. - Well-positioned to continue with R&
...more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Nov 29, 2021 2:54pm
$ACOG Testing Resistance up ~5% On the Day So Far
Alpha Cognition $ACOG/$ACOG.V is testing support at $1.12 today and I’m looking for a break above the current bearish trend as shares are up ~5% today. The RSI and Stochastic oscillator are currently
...more
(144)
•••
culturedpiggy01
X
View Profile
View Bullboard History
Post by
culturedpiggy01
on Nov 26, 2021 2:23pm
$ACOG.V ceo talks new treatment for Alzheimer's symptoms
great video of $ACOG.V CEO talking about possible treatments in development for treating the symptoms of Alzheimer’s https://www.youtube.com/watch?v=4S4g1dVckN8 he also added that results from its
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon